An Open-label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid Cancer

NCT01964144 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yonsei University